Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
NCT Number: NCT02643173
The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.
Looking for future studies?
Notify Me20 year–100 year
All sexes
Observational
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Postoperative 2 year
Seoul National University Bundang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05095519
Adenocarcinoma, Carcinoma
Fitzroy, Victoria, Australia
View Trial DetailsNCT03782207
Adenocarcinoma, Bronchial Neoplasms
Buenos Aires, Argentina
View Trial DetailsNCT04762888
Adenocarcinoma, Carcinoma
Rochester, Minnesota, United States
View Trial DetailsNCT06248554
Adenocarcinoma, Carcinoma
Wuhan, China
View Trial Details